Atrial Fibrillation (AFib) Registry

Veradigm’s Atrial Fibrillation (AFib) Registry

Cardiovascular disease (CVD) remains one of the most prevalent — and urgent — health issues in the world.

Atrial Fibrillation (AFib) is the most common type of treated heart arrythmia. More than 454,000 hospitalizations with AFib as the primary diagnosis happen each year in the U.S. The condition contributes to about 158,000 deaths each year. The death rate from AFib as the primary or a contributing cause of death has been rising for more than two decades.¹

Veradigm Cardiology Registries, operated in collaboration with the American College of Cardiology, encompass cardiology’s largest outpatient quality improvement registry.

Veradigm’s disease registries leverage both structured and unstructured data to provide precise insights into disease patterns, treatment outcomes, and patient care. These registries enable deep, targeted research that drives innovation and enhances real-world clinical insights.

Registry data provides information on diverse patient populations and rich clinical insights.

Key AFib Publications

• Patients and their physician’s perspectives about oral anticoagulation in patients with atrial fibrillation not receiving an anticoagulant
• Sociodemographic determinants of oral anticoagulant prescription in patients with atrial fibrillations: findings from the PINNACLE registry using machine learning

Explore All Veradigm Clinical Data Registry Publications

1. https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html